Singh Ankur, Williams Stevie, Calabrese Angela, Riha Renata
Department of Sleep Medicine, Edinburgh Royal Infirmary, Royal Infirmary of Edinburgh, Scotland, UK.
Sleep Research Unit, The University of Edinburgh Centre for Clinical Brain Sciences, Edinburgh, UK.
J Sleep Res. 2023 Jun;32(3):e13792. doi: 10.1111/jsr.13792. Epub 2022 Nov 30.
Previous studies have shown that rapid eye movement sleep without atonia during polysomnography can predict the risk of phenoconversion to neurodegenerative disease in patients with isolated rapid eye movement sleep behaviour disorder. Discrepancy remains with regards to the morphology of rapid eye movement sleep without atonia that best predicts phenoconversion risk. This study aimed to ascertain the predictive value of tonic, phasic and mixed rapid eye movement sleep without atonia in patients with isolated rapid eye movement sleep behaviour disorder, at time of diagnosis. Sixty-four patients with polysomnography-confirmed isolated rapid eye movement sleep behaviour disorder, including 19 who phenoconverted during follow-up, were identified from an existing database. Tonic, phasic, mixed and "any" rapid eye movement sleep without atonia activity from the mentalis, tibialis anterior and flexor digitorum superficialis muscles was analysed blind to status using the diagnostic polysomnography. Rapid eye movement sleep without atonia variables were compared between converters and non-converters. Rapid eye movement sleep without atonia cut-offs predicting phenoconversion were established using receiver-operating characteristic analysis. The mean follow-up duration was 5.50 ± 4.73 years. Phenoconverters (n = 19) had significantly higher amounts of tonic (22.2 ± 19.1%, p = 0.0014), mixed (18.1 ± 14.1%, p = 0.0074) and "any" (mentalis muscle; 58.7 ± 28.0%, p = 0.0009) and all muscles (68.0 ± 20.8%, p = 0.0049) rapid eye movement sleep without atonia at diagnosis than non-converters. Optimal rapid eye movement sleep without atonia cut-off values predicting phenoconversion were 5.8% for tonic (73.7% sensitivity; 75.6% specificity), 7.3% for mixed (68.4% sensitivity; 73.3% specificity) and 43.6% for "any" (mentalis muscle; 68.4% sensitivity; 80.0% specificity) activity. "Any" (mentalis muscle) rapid eye movement sleep without atonia had the highest area under the curve (0.809) followed by tonic (0.799). The percentage of tonic rapid eye movement sleep without atonia was the strongest biomarker of phenoconversion in this cohort of patients with isolated rapid eye movement sleep behaviour disorder.
既往研究表明,多导睡眠图显示快速眼动睡眠期无张力缺乏可预测孤立性快速眼动睡眠行为障碍患者发生神经退行性疾病表型转化的风险。关于最能预测表型转化风险的无张力缺乏快速眼动睡眠的形态,仍存在差异。本研究旨在确定诊断时,无张力缺乏的紧张性、相位性和混合性快速眼动睡眠在孤立性快速眼动睡眠行为障碍患者中的预测价值。从现有数据库中识别出64例经多导睡眠图确诊的孤立性快速眼动睡眠行为障碍患者,其中19例在随访期间发生了表型转化。使用诊断性多导睡眠图,对颏肌、胫前肌和指浅屈肌的紧张性、相位性、混合性和“任何”无张力缺乏快速眼动睡眠活动进行盲态分析。比较了转化者和未转化者之间无张力缺乏快速眼动睡眠的变量。使用受试者工作特征分析确定预测表型转化的无张力缺乏快速眼动睡眠的临界值。平均随访时间为5.50±4.73年。与未转化者相比,表型转化者(n = 19)在诊断时紧张性(22.2±19.1%,p = 0.0014)、混合性(18.1±14.1%,p = 0.0074)和“任何”(颏肌;58.7±28.0%,p = 0.0009)以及所有肌肉(68.0±20.8%,p = 0.0049)的无张力缺乏快速眼动睡眠量显著更高。预测表型转化的无张力缺乏快速眼动睡眠的最佳临界值为:紧张性5.8%(敏感性73.7%;特异性75.6%),混合性7.3%(敏感性68.4%;特异性73.3%),“任何”(颏肌)43.6%(敏感性68.4%;特异性80.0%)。“任何”(颏肌)无张力缺乏快速眼动睡眠的曲线下面积最大(0.809),其次是紧张性(0.799)。在这组孤立性快速眼动睡眠行为障碍患者中,无张力缺乏紧张性快速眼动睡眠的百分比是表型转化的最强生物标志物。